tiprankstipranks
Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market

Regen Biopharma (RGBP) Financial Statements

64 Followers

Regen Biopharma Financial Overview

Regen Biopharma's market cap is currently ―. The company's EPS TTM is $-0.237; its P/E ratio is -1.30; Regen Biopharma is scheduled to report earnings on May 14, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 31.64K$ 31.64K$ 31.64K$ 31.64K$ 59.06K
Gross Profit$ 31.64K$ 31.64K$ 31.64K$ 31.64K-
EBIT$ -132.83K$ -332.00K$ -85.16K$ 196.97K$ 1.65M
EBITDA$ -128.50K$ -327.63K$ 0.00$ 196.97K$ 1.65M
Net Income Common Stockholders$ -122.47K$ -349.76K$ -99.22K$ 184.89K$ 1.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 78.11K$ 124.50K$ 692.00$ 87.70K$ 40.74K
Total Assets$ 140.77K$ 159.53K$ 285.20K$ 406.63K$ 414.11K
Total Debt$ 693.77K$ 704.07K$ 601.59K$ 601.59K$ 511.59K
Net Debt$ 615.66K$ 579.57K$ 600.90K$ 513.89K$ 470.85K
Total Liabilities$ 5.32M$ 5.40M$ 5.31M$ 5.34M$ 5.30M
Stockholders Equity$ -5.18M$ -5.24M$ -5.03M$ -4.93M$ -4.88M
Cash Flow-
Free Cash Flow$ -209.32K$ -162.34K-$ 46.96K$ -10.46K
Operating Cash Flow$ -209.32K$ -162.34K-$ 46.96K$ -10.46K
Investing Cash Flow----$ 0.00
Financing Cash Flow$ 162.94K$ 165.80K--$ 0.00
Currency in USD

Regen Biopharma Earnings and Revenue History

Regen Biopharma Debt to Assets

Regen Biopharma Cash Flow

Regen Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis